Search clinical trials for: moxifloxacin

Total 588 results

Population Council
Parexel

Completed

A Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers

Healthy

United States
ViiV Healthcare
GlaxoSmithKline

Terminated

A Study to Determine the Effect of Multiple Doses of BMS-955176 on the Electrocardiograph of Healthy Subjects

Infection, Human Immunodeficiency Virus

United States
GlaxoSmithKline

Completed

A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers

Influenza, Human

United States
GlaxoSmithKline

Completed

Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers

Infections, Respiratory Tract

United States
GlaxoSmithKline

Completed

QTc Study GSK573719+GW642444

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

Tafenoquine Thorough QTc Study in Healthy Subjects

Malaria, Vivax

United States
GlaxoSmithKline

Completed

This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers.

Obstetric Labour, Premature

United States
GlaxoSmithKline

Completed

Corrected QT (QTc) Study With Flucticasone Furoate and GW642444

Asthma

United Kingdom
GlaxoSmithKline

Completed

Albiglutide Thorough ECG Study in Healthy Volunteers

Diabetes Mellitus, Type 2
GlaxoSmithKline

Completed

A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin

Acute Coronary Syndrome

United States
Eli Lilly and Company
Incyte Corporation

Completed

A Study of LY3009104 in Healthy Participants

Healthy Participants

United States
Trevena Inc.

Completed

Study of the Effects of TRV130, at Therapeutic and Supra Therapeutic Doses, on QTc Intervals

Healthy

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Lymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Infection | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms

United States
Johns Hopkins University
Universidade Federal do Rio de Janeiro

Terminated

Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis

Tuberculosis

Brazil
William Beaumont Hospitals

Terminated

Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives

Contraception

United States
Global Alliance for TB Drug Development
Sanofi; University College, London; European and Developing Countries Clinical... and other collaborators

Completed

Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis (REMoxTB)

Pulmonary Tuberculosis

China, Zambia, Tanzania, India, Kenya, Malaysia, Mexico, South Africa, Thailand
Melinta Therapeutics, Inc.

Completed

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia (SOLITAIRE-ORAL)

Community-acquired Bacterial Pneumonia

Spain, United States, Hungary, Canada, Estonia, Russian Federation, Argentina, Bulgaria, Czech Republic, Dominican Republic, Ecuador, Germany, Latvia, Poland, Puerto Rico, Romania, South Africa
Melinta Therapeutics, Inc.

Completed

Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia (SOLITAIRE-IV)

Community-acquired Bacterial Pneumonia

Spain, United States, Philippines, Taiwan, Canada, Germany, Poland, Russian Federation, Argentina, Bulgaria, South Africa, Slovenia, Serbia, Colombia, Hungary, Netherlands, Slovakia, Ukraine, Peru, Latvia, Guatemala, Romania, Chile, G... and more
Centers for Disease Control and Prevention
AIDS Clinical Trials Group

Unknown

Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis (S31PK/PD)

Tuberculosis

Uganda
Global Alliance for TB Drug Development

Completed

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001)

Pulmonary Tuberculosis

South Africa
Genentech, Inc.

Completed

A Study to Investigate the Effect of GDC-0449 on the QT/QTc Interval in Healthy Female Subjects

Healthy Volunteer
Poxel SA

Completed

Effect of Imeglimin on QT/QTc Intervals in Healthy Subjects

Qt Interval, Variation in

United Kingdom
Intarcia Therapeutics

Completed

Study of the Effects of Intravenous Exenatide on Cardiac Repolarization

Healthy Adult Male and Female Volunteers

Netherlands
Cubist Pharmaceuticals LLC

Completed

Safety Study Designed to Study the Effects of Two Different Doses of CXA-101/Tazobactam, a Low Dose and a High Dose, on the QT/QTc Intervals in Healthy Subjects

Healthy

United States
Novo Nordisk A/S

Completed

Effect of Liraglutide on Heart Frequency in Healthy Volunteers

Diabetes Mellitus, Type 2 | Diabetes

United States
Xijing Hospital of Digestive Diseases

Completed

Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy

Gastritis | Dyspepsia | Peptic Ulcer

China
Horizon Pharma Ireland, Ltd., Dublin Ireland

Completed

Double-Blind Randomized Crossover Trial to Access Electrocardiogram Effects of HPN-100

Drug Toxicity

United States
University of Virginia

Completed

Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma (MEL53)

Melanoma

United States
Janssen Research & Development, LLC

Completed

Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Chinese Healthy Participants

Healthy

China
Alcon Research

Completed

AL-15469A for the Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis

United States
University Medical Center Groningen

Terminated

Pharmacokinetics and Safety of Moxifloxacin (MFX468)

Tuberculosis

Netherlands
Hoffmann-La Roche

Completed

A Two-part, Single-dose, Randomized Study to Evaluate the Safety of Supra-therapeutic Doses of RO7033877 and to Investigate the Effect of RO7033877 on the QTc Interval

Healthy Volunteer

United States
Hoffmann-La Roche

Completed

A Study of the Effect of RO4917838 on the QTcF Interval in Healthy Volunteers

Healthy Volunteer

United States, France
Hoffmann-La Roche

Completed

A 2-Part Study to Evaluate the Safety of Supra-Therapeutic Doses of RO4602522 and to Investigate the Effect of RO4602522 on the QTc Interval

Healthy Volunteer

United States
Hoffmann-La Roche

Completed

A Study of Danoprevir in Combination With Low-Dose Ritonavir in Healthy Subjects

Healthy Volunteer

France
Orexigen Therapeutics, Inc

Completed

Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants

Heart Repolarization

United States
GlaxoSmithKline

Completed

Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart

Atherosclerosis

United States
Achieve Life Sciences
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac Repolarization

Cardiac Conduction and Repolarization

United States
VA Office of Research and Development
University Hospitals Cleveland Medical Center

Terminated

Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis

Psoriasis

United States
Johnson & Johnson Pharmaceutical Research & Development...

Withdrawn

A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives

Nervous System Malformations | Neural Tube Defects | Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Effect of Mipomersen on Cardiac Repolarization Conducted in Healthy Subjects

Healthy

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess Electrocardiogram Results in Healthy Volunteers Receiving Canagliflozin (JNJ-28431754)

Healthy

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Effect of JNJ-63623872 on Cardiac Repolarization Interval in Healthy Participants

Healthy

Belgium
Food and Drug Administration (FDA)
Spaulding Clinical Research LLC

Completed

Ability of Late Sodium or Calcium Current Block to Balance the ECG Effects of Potassium Current Block

Pharmacokinetics | Pharmacodynamics | Drug-induced QT Prolongation
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Effects of Ibrutinib on Cardiac Repolarization in Healthy Participants

Healthy

Belgium
Seoul National University Hospital
Seoul National University Bundang Hospital; The Catholic University of Korea; Korea National Enterprise for Clinical Trials

Completed

A Study Study to Investigate the Effect on QT/QTc Interval of Moxifloxacin After a Single Dose in Healthy Male Subjects

the Effect of Moxifloxacin on QT/QTc Interval

Korea, Republic of
Boehringer Ingelheim

Completed

Thorough QT Study to Evaluate the Effects of BI 207127 (Deleobuvir) Combined With Faldaprevir on Cardiac Safety Parameters in Healthy Subjects.

Healthy

Germany
Kangbuk Samsung Hospital

Completed

Comparisons of Intravenous Ceftriaxone With Intravenous Moxifloxacin in ERCP

Cholangitis

Korea, Republic of
University of Rochester

Completed

Moxifloxacin vs. Polytrim for Conjunctivitis

Conjunctivitis

United States
University of Pennsylvania
Society of Family Planning

Terminated

Contraceptive Hormones and Women With Cystic Fibrosis

Cystic Fibrosis Exacerbations While on and Off Hormonal Contraception

United States

Search clinical trials for: moxifloxacin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations